Prémaud Aurélie, Rousseau Annick, Picard Nicolas, Marquet Pierre
Department of Pharmacology and Toxicology, Limoges University Hospital, Limoges, France.
Ther Drug Monit. 2006 Apr;28(2):274-7. doi: 10.1097/01.ftd.0000197092.84935.ef.
This study was designed to compare the enzyme multiplied immunoassay technique (EMIT) and a specific ;liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the determination of mycophenolic acid (MPA) concentrations in plasma samples collected from renal transplant patients receiving mycophenolate mofetil in association with sirolimus and corticosteroids. Ten-point blood concentration-time profiles, between pre-dose (C0) and 9-hour post-dose, were obtained on day 7, day 14, months 1, 2, and 3 posttransplantation in 8 patients. MPA plasma concentrations were measured simultaneously with both EMIT and LC-MS/MS. Higher concentrations were obtained with EMIT. The mean (+/-SD) absolute difference was +0.84 +/- 1.93 mg/L, which corresponds to a significant overestimation of 18.7 +/- 2 6.8% with EMIT, with variations depending on the time elapsed since transplantation. An EMIT overestimation of 16.7 +/- 22.5% also was obtained for the MPA areas under the curve calculated using the trapezoidal rule.
本研究旨在比较酶放大免疫分析技术(EMIT)和一种特定的液相色谱-串联质谱法(LC-MS/MS),用于测定从接受霉酚酸酯与西罗莫司及皮质类固醇联合治疗的肾移植患者采集的血浆样本中霉酚酸(MPA)的浓度。在8例患者移植后的第7天、第14天、第1个月、第2个月和第3个月,获取了给药前(C0)至给药后9小时的十点血药浓度-时间曲线。同时用EMIT和LC-MS/MS测定MPA血浆浓度。EMIT测得的浓度更高。平均(±标准差)绝对差值为+0.84±1.93mg/L,这对应于EMIT显著高估了18.7±26.8%,其变化取决于移植后的时间。使用梯形法则计算的MPA曲线下面积,EMIT也高估了16.7±22.5%。